Company / Revenue per Share
IRADIMED CORP Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$6.59
FY2025
5-year range
$3.13 / $6.59
FY2021-FY2025
Trend
+14.0%
vs FY2024
Sector context
#126 of 153
Health Care
What the data says
IRADIMED CORP's revenue per share of $6.59 is lower than 82% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 5 consecutive years, from $2.70 in FY2020 to $6.59 in FY2025.
Based on SEC 10-K filings.
6.59 in FY2025 with a 5-year CAGR of +19.6%.
Improved from $5.21 to $6.59 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +25.7%
- 5-Year CAGR
- +19.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 153This company $6.59 Sector average $123.62
▼
-94.7% below sector average
Key checks
Key Insights
- IRADIMED CORP's revenue per share has grown for 5 consecutive years.
- In FY2025, revenue per share increased 14.0% year-over-year.
- Ranks #126 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.59 | +14.0% |
| FY2024 | $5.79 | +11.1% |
| FY2023 | $5.21 | +56.8% |
| FY2022 | $3.32 | +6.1% |
| FY2021 | $3.13 | +16.1% |
| FY2020 | $2.70 | -23.1% |
| FY2019 | $3.51 | +14.3% |
| FY2018 | $3.07 | +4.1% |
| FY2017 | $2.95 | +110.4% |
| FY2016 | $1.40 | -3.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026